{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:16:49Z","timestamp":1771561009842,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":153,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1124\/dmd.124.001684","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T18:30:31Z","timestamp":1716316231000},"page":"836-846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Cytochrome P450 2C8*3 Variant (rs11572080) Is Associated with Improved Asthma Symptom Control in Children and Altered Lipid Mediator Production and Inflammatory Response in Human Bronchial Epithelial Cells"],"prefix":"10.1016","volume":"52","author":[{"given":"Marysol","family":"Almestica-Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam D.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha N.","family":"Serna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine L.","family":"Burrell-Gerbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tosifa A.","family":"Memon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan L.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flory L.","family":"Nkoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra E.","family":"Deering-Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Rower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-1982","authenticated-orcid":false,"given":"Christopher A.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.124.001684_bib1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/FPC.0b013e3283653b27","article-title":"PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8","volume":"23","author":"Aquilante","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.124.001684_bib2","series-title":"Comprehensive Pharmacology","first-page":"657","article-title":"Pharmacogenetics\/pharmacogenomics of drug-metabolizing enzymes and transporters","author":"Arbitrio","year":"2022"},{"key":"10.1124\/dmd.124.001684_bib3","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1183\/13993003.01080-2015","article-title":"Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD","volume":"47","author":"Balgoma","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1124\/dmd.124.001684_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1710-1492-10-21","article-title":"Effectiveness of montelukast administered as monotherapy or in combination with inhaled corticosteroid in pediatric patients with uncontrolled asthma: a prospective cohort study","volume":"10","author":"B\u00e9rub\u00e9","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1124\/dmd.124.001684_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-nutr-071813-105747","article-title":"Lipid-metabolizing CYPs in the regulation and dysregulation of metabolism","volume":"34","author":"Bishop-Bailey","year":"2014","journal-title":"Annu Rev Nutr"},{"key":"10.1124\/dmd.124.001684_bib6","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1124\/dmd.115.065763","article-title":"In vitro metabolism of montelukast by cytochrome P450s (CYPs) and UDP-glucuronosyltransferases (UGTs)","volume":"43","author":"Cardoso","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001684_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003088-200241010-00003","article-title":"Clinical pharmacokinetics of salmeterol","volume":"41","author":"Cazzola","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.124.001684_bib8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/cea.12506","article-title":"Mechanisms of airway hyper-responsiveness in asthma: the past, present and yet to come","volume":"45","author":"Chapman","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1124\/dmd.124.001684_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00008571-200110000-00006","article-title":"Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid","volume":"11","author":"Dai","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.124.001684_bib10","doi-asserted-by":"crossref","first-page":"24866","DOI":"10.1074\/jbc.M116.746156","article-title":"Characterization of transient receptor potential vanilloid-1 (TRPV1) variant activation by coal fly ash particles and associations with altered transient receptor potential ankyrin-1 (TRPA1) expression and asthma","volume":"291","author":"Deering-Rice","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.124.001684_bib11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3389\/fphar.2019.01094","article-title":"Montelukast improves symptoms and lung function in asthmatic women compared with men","volume":"10","author":"Esposito","year":"2019","journal-title":"Front Pharmacol"},{"issue":"5 Suppl","key":"10.1124\/dmd.124.001684_bib12","first-page":"S93","article-title":"Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007","volume":"120","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/dmd.124.001684_bib13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10555-011-9302-3","article-title":"The cytochrome P450 pathway in angiogenesis and endothelial cell biology","volume":"30","author":"Fleming","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"10.1124\/dmd.124.001684_bib14","doi-asserted-by":"crossref","first-page":"E3240","DOI":"10.1073\/pnas.1521453113","article-title":"CYP450-derived oxylipins mediate inflammatory resolution","volume":"113","author":"Gilroy","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.124.001684_bib15","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1007\/s00216-017-0243-8","article-title":"Mass spectrometry profiling of oxylipins, endocannabinoids, and N-acylethanolamines in human lung lavage fluids reveals responsiveness of prostaglandin E2 and associated lipid metabolites to biodiesel exhaust exposure","volume":"409","author":"Gouveia-Figueira","year":"2017","journal-title":"Anal Bioanal Chem"},{"key":"10.1124\/dmd.124.001684_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41397-022-00284-6","article-title":"The clinically relevant CYP2C8*3 and CYP2C9*2 haplotype is inherited from Neandertals","volume":"22","author":"Haeggstr\u00f6m","year":"2022","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.124.001684_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41577-020-00477-9","article-title":"Regulation of immune responses by the airway epithelial cell landscape","volume":"21","author":"Hewitt","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/dmd.124.001684_bib18","doi-asserted-by":"crossref","first-page":"108484","DOI":"10.1016\/j.jnutbio.2020.108484","article-title":"Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies","volume":"86","author":"Hildreth","year":"2020","journal-title":"J Nutr Biochem"},{"key":"10.1124\/dmd.124.001684_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cpt.891","article-title":"Comprehensive pharmacogenomic study reveals an important role of UGT1A3 in montelukast pharmacokinetics","volume":"104","author":"Hirvensalo","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001684_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02714065","article-title":"Neutrophil-derived epoxide, 9,10-epoxy-12-octadecenoate, induces pulmonary edema","volume":"166","author":"Hu","year":"1988","journal-title":"Lung"},{"key":"10.1124\/dmd.124.001684_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/20024091064273","article-title":"Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung","volume":"32","author":"Hukkanen","year":"2002","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/dmd.124.001684_bib22","doi-asserted-by":"crossref","first-page":"122s","DOI":"10.1183\/09031936.01.18s320122","article-title":"Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD","volume":"32","author":"Hukkanen","year":"2001","journal-title":"Eur Respir J Suppl"},{"key":"10.1124\/dmd.124.001684_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3390\/genes9050237","article-title":"Genetic mechanisms of asthma and the implications for drug repositioning","volume":"9","author":"Huo","year":"2018","journal-title":"Genes"},{"key":"10.1124\/dmd.124.001684_bib24","first-page":"e5046","article-title":"Role of montelukast in improving quality of life in patients with persistent asthma","volume":"11","author":"Ikram","year":"2019","journal-title":"Cureus"},{"key":"10.1124\/dmd.124.001684_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2125.2011.04086.x","article-title":"CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast","volume":"73","author":"Karonen","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.124.001684_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1183\/09031936.00209412","article-title":"Lipid mediator profiles differ between lung compartments in asthmatic and healthy humans","volume":"43","author":"Larsson","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1124\/dmd.124.001684_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4168\/aair.2021.13.3.375","article-title":"Biomarkers for severe asthma: lessons from longitudinal cohort studies","volume":"13","author":"Lee","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1124\/dmd.124.001684_bib28","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41564-019-0498-2","article-title":"Elevated faecal 12,13-diHOME concentration in neonates at high risk for asthma is produced by gut bacteria and impedes immune tolerance","volume":"4","author":"Levan","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1124\/dmd.124.001684_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12871-018-0490-z","article-title":"Deletion of soluble epoxide hydrolase attenuates mice hyperoxic acute lung injury","volume":"18","author":"Liu","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"10.1124\/dmd.124.001684_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023864","article-title":"Asthmatics exhibit altered oxylipin profiles compared to healthy individuals after subway air exposure","volume":"6","author":"Lundstr\u00f6m","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/dmd.124.001684_bib31","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/mnfr.201200827","article-title":"Lipid mediator serum profiles in asthmatics significantly shift following dietary supplementation with omega-3 fatty acids","volume":"57","author":"Lundstr\u00f6m","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"10.1124\/dmd.124.001684_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033780","article-title":"Allergic asthmatics show divergent lipid mediator profiles from healthy controls both at baseline and following birch pollen provocation","volume":"7","author":"Lundstr\u00f6m","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/dmd.124.001684_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.plefa.2014.10.006","article-title":"Epoxyeicosatrienoic acids attenuate cigarette smoke extract-induced interleukin-8 production in bronchial epithelial cells","volume":"94","author":"Ma","year":"2015","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1124\/dmd.124.001684_bib34","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.4049\/jimmunol.181.5.3540","article-title":"Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma","volume":"181","author":"Mabalirajan","year":"2008","journal-title":"J Immunol"},{"key":"10.1124\/dmd.124.001684_bib35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0959-8049(98)00034-3","article-title":"Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues","volume":"34","author":"Mac\u00e9","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1124\/dmd.124.001684_bib36","doi-asserted-by":"crossref","first-page":"663869","DOI":"10.3389\/fphys.2021.663869","article-title":"Plasma linoleate diols are potential biomarkers for severe COVID-19 infections","volume":"12","author":"McReynolds","year":"2021","journal-title":"Front Physiol"},{"key":"10.1124\/dmd.124.001684_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1183\/09031936.00023608","article-title":"Airway hyperresponsiveness in asthma: lessons from in vitro model systems and animal models","volume":"32","author":"Meurs","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1124\/dmd.124.001684_bib38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nm0597-562","article-title":"Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase","volume":"3","author":"Moghaddam","year":"1997","journal-title":"Nat Med"},{"key":"10.1124\/dmd.124.001684_bib39","doi-asserted-by":"crossref","first-page":"L1289","DOI":"10.1152\/ajplung.00356.2006","article-title":"Regulation of interleukin-8 via an airway epithelial signaling cascade","volume":"292","author":"Nakanaga","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/dmd.124.001684_bib40","doi-asserted-by":"crossref","first-page":"20120431","DOI":"10.1098\/rstb.2012.0431","article-title":"Human cytochromes P450 in health and disease","volume":"368","author":"Nebert","year":"2013","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1124\/dmd.124.001684_bib41","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1465-9921-11-28","article-title":"Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function","volume":"11","author":"Neveu","year":"2010","journal-title":"Respir Res"},{"key":"10.1124\/dmd.124.001684_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1109\/JSEN.2009.2035736","article-title":"Endogenous levels of five fatty acid metabolites in exhaled breath condensate to monitor asthma by high-performance liquid chromatography: electrospray tandem mass spectrometry","volume":"10","author":"Nording","year":"2010","journal-title":"IEEE Sens J"},{"key":"10.1124\/dmd.124.001684_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7243\/2059-0008-1-1","article-title":"Bioactive lipid profiling reveals drug target engagement of a soluble epoxide hydrolase inhibitor in a murine model of tobacco smoke exposure","volume":"1","author":"Nording","year":"2015","journal-title":"J Metabolomics"},{"key":"10.1124\/dmd.124.001684_bib44","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/ajrccm\/137.3.535","article-title":"Existence of leukotoxin 9,10-epoxy-12-octadecenoate in lung lavages from rats breathing pure oxygen and from patients with the adult respiratory distress syndrome","volume":"137","author":"Ozawa","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1124\/dmd.124.001684_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/2040622310383343","article-title":"Montelukast in asthma: a review of its efficacy and place in therapy","volume":"2","author":"Paggiaro","year":"2011","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1124\/dmd.124.001684_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-4939-7592-1_13","article-title":"Establishing and performing targeted multi-residue analysis for lipid mediators and fatty acids in small clinical plasma samples","volume":"1730","author":"Pedersen","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.124.001684_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1081-1206(10)62058-3","article-title":"Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids","volume":"91","author":"Phipatanakul","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1124\/dmd.124.001684_bib48","doi-asserted-by":"crossref","first-page":"27009","DOI":"10.1289\/EHP11076","article-title":"Mechanisms and consequences of variable TRPA1 expression by airway epithelial cells: effects of TRPV1 genotype and environmental agonists on cellular responses to pollutants in vitro and asthma","volume":"131","author":"Rapp","year":"2023","journal-title":"Environ Health Perspect"},{"key":"10.1124\/dmd.124.001684_bib49","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.7150\/ijbs.4874","article-title":"Role of IL-6 in asthma and other inflammatory pulmonary diseases","volume":"8","author":"Rincon","year":"2012","journal-title":"Int J Biol Sci"},{"key":"10.1124\/dmd.124.001684_bib50","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.112.202556","article-title":"Metabolism of beclomethasone dipropionate by cytochrome P450 3A enzymes","volume":"345","author":"Roberts","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001684_bib51","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3389\/fphar.2018.01572","article-title":"Deficiency of soluble epoxide hydrolase protects cardiac function impaired by LPS-induced acute inflammation","volume":"9","author":"Samokhvalov","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.124.001684_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4168\/aair.2016.8.6.481","article-title":"Eicosanoid mediators in the airway inflammation of asthmatic patients: what is new?","volume":"8","author":"Sanak","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1124\/dmd.124.001684_bib53","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1021\/tx400024h","article-title":"Activation of transient receptor potential ankyrin-1 (TRPA1) in lung cells by wood smoke particulate material","volume":"26","author":"Shapiro","year":"2013","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.124.001684_bib54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1006\/abbi.2001.2434","article-title":"Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction","volume":"392","author":"Sisemore","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.124.001684_bib55","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.0409591102","article-title":"Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor","volume":"102","author":"Smith","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.124.001684_bib56","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jpeds.2012.11.031","article-title":"Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control","volume":"162","author":"Stockmann","year":"2013","journal-title":"J Pediatr"},{"key":"10.1124\/dmd.124.001684_bib57","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaci.2015.02.009","article-title":"Effect of CYP3A5*3 on asthma control among children treated with inhaled beclomethasone","volume":"136","author":"Stockmann","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/dmd.124.001684_bib58","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/ijerph18030992","article-title":"The impact of tobacco smoking on adult asthma outcomes","volume":"18","author":"Tiotiu","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1124\/dmd.124.001684_bib59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/tpj.2010.28","article-title":"Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs","volume":"11","author":"Wang","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.124.001684_bib60","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1165\/rcmb.2011-0359OC","article-title":"Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease","volume":"46","author":"Wang","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/dmd.124.001684_bib61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1165\/rcmb.2013-0440OC","article-title":"Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice","volume":"52","author":"Yang","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/dmd.124.001684_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.124.001684_bib63","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.rmed.2010.06.018","article-title":"Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease","volume":"104","author":"Zhao","year":"2010","journal-title":"Respir Med"},{"key":"10.1124\/dmd.124.001684_bib64","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1165\/ajrcmb.25.4.4104","article-title":"Leukotoxin-diol: a putative toxic mediator involved in acute respiratory distress syndrome","volume":"25","author":"Zheng","year":"2001","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624006731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624006731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.124.001684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T03:56:06Z","timestamp":1743652566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624006731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":64,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0090955624006731"],"URL":"https:\/\/doi.org\/10.1124\/dmd.124.001684","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cytochrome P450 2C8*3 Variant (rs11572080) Is Associated with Improved Asthma Symptom Control in Children and Altered Lipid Mediator Production and Inflammatory Response in Human Bronchial Epithelial Cells","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.124.001684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The Author(s)","name":"copyright","label":"Copyright"}]}}